eEF-2K knockdown synergizes with STS treatment to inhibit cell proliferation, migration, and invasion via the TG2/ERK pathway in A549 cells

J Biochem Mol Toxicol. 2022 Oct;36(10):e23158. doi: 10.1002/jbt.23158. Epub 2022 Jul 17.

Abstract

Emerging research has suggested the anticancer potential of tanshinone IIA, the bioactive ingredient isolated from the traditional Chinese herb Salvia miltiorrhiza. However, the molecular mechanism of sodium tanshinone IIA sulfonate (STS) antilung cancer effect is not very clear. In this study, our purpose is to investigate the roles of STS and elongation factor-2 kinase (eEF-2K) in regulating the proliferation, migration, and invasion of A549 cells and explore the implicated pathways. We found that STS suppressed A549 cell survival and proliferation in a time- and xdose-dependent manner. Knockdown of eEF-2K and treatment with STS synergistically exerted antiproliferative, -migratory, and -invasive effects on A549 cells. These effects were caused by attenuation of the extracellular signal-regulated kinase (ERK) pathway via inhibition of tissue transglutaminase (TG2). In summary, the inhibition of eEF-2K synergizes with STS treatment, exerting anticancer effects on lung adenocarcinoma cells through the TG2/ERK signaling pathway, which provides a potential therapeutic target for treating lung adenocarcinoma.

Keywords: elongation factor-2 kinase; extracellular signal-regulated kinase; lung adenocarcinoma; sodium tanshinone IIA sulfonate; tissue transglutaminase.

MeSH terms

  • A549 Cells
  • Adenocarcinoma of Lung*
  • Cell Proliferation
  • Extracellular Signal-Regulated MAP Kinases*
  • Humans
  • MAP Kinase Signaling System
  • Peptide Elongation Factors / pharmacology

Substances

  • Peptide Elongation Factors
  • Extracellular Signal-Regulated MAP Kinases